Serotonergic system in hypoxic ventilatory response in unilateral rat model of Parkinson’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1423-0127
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Serotonergic system in hypoxic ventilatory response in unilateral rat model of Parkinson’s disease ; volume:24 ; number:1 ; day:27 ; month:3 ; year:2017 ; pages:1-10 ; date:12.2017
Journal of biomedical science ; 24, Heft 1 (27.3.2017), 1-10, 12.2017
- Classification
-
Biowissenschaften, Biologie
- Creator
-
Andrzejewski, Kryspin
- Contributor
-
Kaczyńska, Katarzyna
Zaremba, Małgorzata
SpringerLink (Online service)
- DOI
-
10.1186/s12929-017-0331-2
- URN
-
urn:nbn:de:1111-201704152100
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Andrzejewski, Kryspin
- Kaczyńska, Katarzyna
- Zaremba, Małgorzata
- SpringerLink (Online service)
Other Objects (12)
The serotonergic system in Parkinson’s patients with dyskinesia: evidence from imaging studies
Early Degeneration of Both Dopaminergic and Serotonergic Axons – A Common Mechanism in Parkinson’s Disease
Analysis of a murine Pink1 deficiency in serotonergic and dopaminergic neurons in respect of Parkinson´s disease
Parkinson’s disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report
Parkinson
Parkinson
Correction: Parkinson’s disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report
Raphe serotonergic neurons modulate genioglossus corticomotor activity in intermittent hypoxic rats
Effects of right-unilateral 6-hydroxydopamine infusion-induced memory impairment and oxidative stress: relevance for Parkinson’s disease
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
The serotonergic system in Parkinson’s patients with dyskinesia: evidence from imaging studies
Early Degeneration of Both Dopaminergic and Serotonergic Axons – A Common Mechanism in Parkinson’s Disease
Analysis of a murine Pink1 deficiency in serotonergic and dopaminergic neurons in respect of Parkinson´s disease
Parkinson’s disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report
Parkinson
Parkinson
Correction: Parkinson’s disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report
Raphe serotonergic neurons modulate genioglossus corticomotor activity in intermittent hypoxic rats
Effects of right-unilateral 6-hydroxydopamine infusion-induced memory impairment and oxidative stress: relevance for Parkinson’s disease
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
The serotonergic system in Parkinson’s patients with dyskinesia: evidence from imaging studies
Early Degeneration of Both Dopaminergic and Serotonergic Axons – A Common Mechanism in Parkinson’s Disease
Analysis of a murine Pink1 deficiency in serotonergic and dopaminergic neurons in respect of Parkinson´s disease
Parkinson’s disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report
Parkinson
Parkinson
Correction: Parkinson’s disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report
Raphe serotonergic neurons modulate genioglossus corticomotor activity in intermittent hypoxic rats
Effects of right-unilateral 6-hydroxydopamine infusion-induced memory impairment and oxidative stress: relevance for Parkinson’s disease
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease